Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
J Atheroscler Thromb ; 17(7): 730-9, 2010 Jul 30.
Article in English | MEDLINE | ID: mdl-20523012

ABSTRACT

AIM: Platelets plays a central role in hemostatic processes and consequently are similarly involved in pathological processes, such as arterial thrombosis and atherosclerosis. Herein we described the synthesis, antiplatelet profile and structure-activity relationship (SAR) of a new series of N'-substitutedphenylmethylene-1H-pyrazolo[3,4-b]pyridine-carbohydrazide derivatives (3a-3k). METHODS: These compounds were synthesized in good yield and tested in platelet aggregation assays using collagen, ADP and arachidonic acid as agonists. We also performed a SAR studies using SPARTAN' 08 program, in silico ADMET screening and the Lipinski " rule of five " using Osiris Property Explorer and molinspiration on-line programs. RESULTS: Interestingly, the new compounds were active against collagen and arachidonic acid (AA) with the two most actives compounds (3a and 3c - IC(50)=61 microM and 68 microM respectively) almost 5-fold more potent than aspirin (IC(50)=300 microM). These derivatives showed low theoretical toxicity risks in in silico ADMET screening and fulfilled the Lipinski rule of five, suggesting good oral biodisponibility. CONCLUSION: This work showed carbohydrazide group as potential for designing new antiplatelets. On that purpose, 3a and 3c may act as prototypes to generate more efficient and safe molecules for treating thrombotic diseases.


Subject(s)
Blood Platelets/drug effects , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation/drug effects , Pyrazoles/pharmacology , Pyridines/pharmacology , Thrombosis/drug therapy , Dose-Response Relationship, Drug , Humans , Molecular Structure , Platelet Aggregation Inhibitors/chemical synthesis , Platelet Aggregation Inhibitors/chemistry , Pyrazoles/chemical synthesis , Pyrazoles/chemistry , Pyridines/chemical synthesis , Pyridines/chemistry , Structure-Activity Relationship , Thrombosis/pathology
2.
Rev. ciênc. farm. básica apl ; 29(2): 149-158, 2008. tab, graf
Article in Portuguese | LILACS | ID: lil-514284

ABSTRACT

O presente estudo avaliou sistemas baseados em bentonita sódica purificada e bentonita sódica purificada intercalada com colina como promotores de dissolução de clorpropamida. A intercalação da bentonita sódica foi avaliada por difração de raios X, análise termo gravimétrica, análise calorimétricade varredura e espectrometria no infravermelho. Prepararam-se misturas físicas, empastamentos (kneadings) e granulados e comprimidos, por granulação úmida e compressão direta; ambos os sistemas (físicos e comprimidos) com diversas relações fármaco: promotores de dissolução. Todos os sistemas físicos e os comprimidos foram avaliados quanto à dissolução do fármaco segundo metodologia descrita na Farmacopéia Norte-Americana (USP). Os comprimidos ainda foram avaliados quanto à dureza e friabilidade. O empastamento hidroalcoólico mostrou ser o melhor sistema físico para aumento da dissolução, entretanto é inviável para produção industrial de comprimidos. Os comprimidos de clorpropamida preparados por granulação úmida com proporção de fármaco e promotores de dissolução de 1:0,25 p/p apresentaram melhores resultados no teste de dissolução em relação aos comprimidos sem os promotores. Não houve diferença significativa entre a liberação de clorpropamida com a bentonita sódica e bentonita sódica intercalada. Os comprimidos preparados por compressão direta apresentaram, comparativamente, o melhor desempenho no teste de dissolução. Não foi evidenciado perda de cristalinidade do fármaconos sistemas estudados. O poder de desintegração da bentonita e a possível interação molecular entre o fármaco e a bentonita são as prováveis causas do aumento da dissolução da clorpropamida com tais sistemas baseados em bentonita.


Subject(s)
Bentonite/pharmacology , Chlorpropamide/pharmacokinetics , Tablets
3.
Curr Med Chem ; 13(3): 313-24, 2006.
Article in English | MEDLINE | ID: mdl-16475939

ABSTRACT

Human Immunodeficiency Virus type 1 Reverse Transcriptase (HIV-1 RT) is one of the most important targets for treatment of Acquired Immune Deficiency Syndrome (AIDS). It catalyzes the reverse transcription of HIV-RNA into a double stranded DNA, and the knowledge of its substrate specificity and catalytic mechanism has guided the development of several inhibitors widely used on current HIV/AIDS therapy. However, mutations in HIV-1 RT structure can lead to the emergence of drug-resistant virus strains. The goal of this review is to summarize relevant structural features of HIV-1 RT and its inhibitors in such a way that this cost-effective target in the development of new antiretroviral drugs is particularly highlighted.


Subject(s)
HIV Reverse Transcriptase/drug effects , HIV-1/enzymology , Drug Resistance, Viral , HIV Infections/drug therapy , HIV Reverse Transcriptase/chemistry , HIV Reverse Transcriptase/genetics , HIV-1/genetics , HIV-1/physiology , Humans , Models, Molecular , Protein Conformation , Reverse Transcriptase Inhibitors/pharmacology , Reverse Transcriptase Inhibitors/therapeutic use , Virus Replication
4.
FEBS Lett ; 574(1-3): 192-202, 2004 Sep 10.
Article in English | MEDLINE | ID: mdl-15358564

ABSTRACT

Eukaryotic DNA replication requires an ordered and regulated machinery to control G1/S transition. The formation of the pre-replicative complex (pre-RC) is a key step involved in licensing DNA for replication. Here, we identify all putative components of the full pre-RC in the genome of the model plant Arabidopsis thaliana. Different from the other eukaryotes, Arabidopsis houses in its genome two putative homologs of ORC1, CDC6 and CDT1. Two mRNA variants of AtORC4 subunit, with different temporal expression patterns, were also identified. Two-hybrid binary interaction assays suggest a primary architectural organization of the Arabidopsis ORC, in which AtORC3 plays a central role in maintaining the complex associations. Expression profiles differ among pre-RC components suggesting the existence of various forms of the complex, possibly playing different roles during development. In addition, the expression of the putative pre-RC genes in non-proliferating plant tissues suggests that they might have roles in processes other than DNA replication licensing.


Subject(s)
Arabidopsis/genetics , Genome, Plant , Base Sequence , DNA Primers , Phylogeny , Polymerase Chain Reaction
5.
Drug Dev Ind Pharm ; 27(1): 103-6, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11247531

ABSTRACT

This report deals with a new procedure suitable for the extraction of coumarin 1 from Mikania glomerata. The aim of this investigation is to obtain this compound in an economically profitable way, taking into account the yield of its extraction, the cost, and the time of the overall process. Fresh and dried plants collected in several areas of the State of Rio de Janeiro were used, and seasonal effects on coumarin content were studied. Obtained results indicated that extraction with a 1% (w/v) NaOH solution, under appropriate conditions, allows a simple and complete recovery of the desired product and that the best yields were obtained with the fresh aerial parts of the plant. Season and area of harvesting effects have also been studied.


Subject(s)
Coumarins/isolation & purification , Plant Extracts/isolation & purification , Costs and Cost Analysis , Drug Industry/economics , Seasons , Sodium Hydroxide/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...